Table 3.

Associations of Lp(a) and risk of CHD are presented as hazard ratios and adjusted for age, sex, smoking, hypertension medication, systolic blood pressure, diabetes, non-Lp(a) LDL-C, HDL-C, and log-triglycerides. Lp(a) was examined as a categorical variable (30 and 50 mg/dL cut points).

	Blacks	Caucasians	Chinese Americans	Hispanics	All Groups
N	1323	1677	548	1044	4593
CHD events (%)	66 (4.9)	102 (6.0)	18 (3.3)	49 (4.6)	5.03%
≥ 30 mg/dL
N (%) †	774 (57.5)	423 (24.8)	108 (19.3)	258 (24.2)	1563 (33.4)
Estimated HR	1.87	1.44	1.39	1.46	1.6
95% CI	(1.08, 3.21)	(0.95, 2.18)	(0.47, 4.08)	(0.78, 2.75)	(1.21, 2.10)
P value	0.024*	0.088	0.55	0.23	<0.001*
≥ 50 mg/dL
N (%) **	445 (33.0)	255 (14.9)	54 (9.7)	140 (13.2)	894 (19.1)
Estimated HR	1.69	1.82	1.04	2.37	1.83
95% CI	(1.03, 2.76)	(1.15, 2.88)	(0.22, 4.98)	(1.17, 4.78)	(1.36, 2.46)
P value	0.037*	0.010*	0.96	0.017*	<0.001*

^*P value of <0.05 indicates significance.

^†number of individuals with Lp(a) ≥ 30 mg/dL;

^**number of individuals with Lp(a) ≥ 50 mg/dL.